Alliancebernstein L.P. Geron Corp Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Geron Corp stock. As of the latest transaction made, Alliancebernstein L.P. holds 1,229,782 shares of GERN stock, worth $4.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,229,782

Previous 599,291 105.21%

Holding current value

$4.91 Million

Previous $2.54 Million 119.8%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.17 - $4.99 $2.63 Million - $3.15 Million	630,491 Added 105.21%	1,229,782 $5.58 Million
Q2 2024 Aug 14, 2024	BUY	$3.1 - $5.09 $268,305 - $440,539	86,550 Added 16.88%	599,291 $2.54 Million
Q2 2023 Aug 15, 2023	BUY	$1.97 - $3.69 $299,302 - $560,621	151,930 Added 42.11%	512,741 $1.65 Million
Q1 2023 May 15, 2023	BUY	$2.14 - $3.4 $37,022 - $58,820	17,300 Added 5.04%	360,811 $782,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $2.42 $310,183 - $369,776	-152,800 Reduced 30.79%	343,511 $831,000
Q3 2022 Nov 15, 2022	SELL	$1.67 - $2.94 $237,808 - $418,656	-142,400 Reduced 22.29%	496,311 $1.16 Million
Q1 2022 May 13, 2022	SELL	$0.99 - $1.6 $15,246 - $24,640	-15,400 Reduced 2.35%	638,711 $869,000
Q3 2021 Nov 10, 2021	SELL	$1.2 - $1.5 $21,720 - $27,150	-18,100 Reduced 2.69%	654,111 $896,000
Q2 2021 Jul 30, 2021	BUY	$1.25 - $1.83 $574,000 - $840,336	459,200 Added 215.58%	672,211 $948,000
Q4 2020 Feb 08, 2021	BUY	$1.55 - $2.05 $3,875 - $5,125	2,500 Added 1.19%	213,011 $339,000
Q3 2020 Nov 12, 2020	SELL	$1.59 - $2.19 $98,103 - $135,123	-61,700 Reduced 22.67%	210,511 $366,000
Q2 2020 Aug 13, 2020	BUY	$1.05 - $2.18 $44,415 - $92,214	42,300 Added 18.4%	272,211 $593,000
Q1 2020 May 14, 2020	BUY	$0.89 - $1.49 $36,668 - $61,388	41,200 Added 21.83%	229,911 $274,000
Q3 2019 Nov 14, 2019	SELL	$1.15 - $1.59 $37,835 - $52,311	-32,900 Reduced 14.85%	188,711 $251,000
Q2 2019 Aug 14, 2019	BUY	$1.37 - $2.02 $10,412 - $15,352	7,600 Added 3.55%	221,611 $312,000
Q1 2019 May 14, 2019	SELL	$1.01 - $1.83 $53,126 - $96,258	-52,600 Reduced 19.73%	214,011 $355,000
Q4 2018 Feb 13, 2019	BUY	$0.98 - $1.85 $38,906 - $73,445	39,700 Added 17.5%	266,611 $267,000
Q2 2018 Aug 13, 2018	BUY	$3.29 - $4.82 $41,125 - $60,250	12,500 Added 5.83%	226,911 $778,000
Q1 2018 May 14, 2018	BUY	$1.81 - $5.98 $61,721 - $203,918	34,100 Added 18.91%	214,411 $911,000
Q4 2017 Feb 13, 2018	SELL	$1.8 - $2.32 $28,080 - $36,192	-15,600 Reduced 7.96%	180,311 $325,000
Q3 2017 Nov 13, 2017	BUY	$1.99 - $2.65 $389,862 - $519,164	195,911	195,911 $427,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.51B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Geron Corp Transaction History